by ged4332 | May 11, 2026
FSB Formalizes Private Credit Risk: $220 to $500 Billion in Bank Exposure Now Under Supervisory Review The Financial Stability Board’s May 6 report formally quantified direct bank exposure to private credit funds at $220 to $500 billion and called for...
by ged4332 | May 11, 2026
The Federal Reserve’s May 2026 Financial Stability Report confirms hedge fund gross notional leverage near record levels, concentrated in the largest funds, while life insurer leverage holds in the top quartile of its historical range, both against a backdrop of...
by ged4332 | Apr 24, 2026
On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962 to impose a 100 percent ad valorem tariff on patented pharmaceutical imports and active pharmaceutical ingredients. The tariff becomes effective July 31,...
by ged4332 | Apr 23, 2026
On April 2, 2026, President Trump issued a proclamation imposing tariffs up to 100 percent on patented pharmaceuticals and active pharmaceutical ingredients (APIs) under Section 232 of the Trade Expansion Act of 1962. The tariffs take effect July 31, 2026 (for major...
by ged4332 | Apr 21, 2026
President Trump’s April 2, 2026, Proclamation under Section 232 of the Trade Expansion Act of 1962 establishes a 100 percent ad valorem tariff on patented pharmaceutical products and their associated active pharmaceutical ingredients (APIs) imported into the...
